These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Differential regulation of muscarinic M1 receptors by orthosteric and allosteric ligands. Davis CN; Bradley SR; Schiffer HH; Friberg M; Koch K; Tolf BR; Bonhaus DW; Lameh J BMC Pharmacol; 2009 Dec; 9():14. PubMed ID: 19951444 [TBL] [Abstract][Full Text] [Related]
28. Long-term wash-resistant effects of brief interaction of xanomeline at the M1 muscarinic receptor. De Lorme KC; Sikorski KL; Grant MK; El-Fakahany EE Neurosci Lett; 2006 Dec; 410(1):11-4. PubMed ID: 17052840 [TBL] [Abstract][Full Text] [Related]
30. Allosteric modulation by persistent binding of xanomeline of the interaction of competitive ligands with the M1 muscarinic acetylcholine receptor. Jakubík J; Tucek S; El-Fakahany EE J Pharmacol Exp Ther; 2002 Jun; 301(3):1033-41. PubMed ID: 12023535 [TBL] [Abstract][Full Text] [Related]
31. Effects of muscarinic toxins MT2 and MT7, from green mamba venom, on m1, m3 and m5 muscarinic receptors expressed in Chinese Hamster Ovary cells. Bradley KN; Rowan EG; Harvey AL Toxicon; 2003 Feb; 41(2):207-15. PubMed ID: 12565740 [TBL] [Abstract][Full Text] [Related]
32. High-Throughput Agonist Shift Assay Development for the Analysis of M Homsher MF; Beshore DC; Cassaday J; Squadroni B; Mohammed E; Hartnett M; Day S; Ma L; Pechter D; Smith MD; Monsma F; Zuck P; Finley MF; Uebele VN; Hermes JD SLAS Discov; 2017 Sep; 22(8):1060-1066. PubMed ID: 28426939 [TBL] [Abstract][Full Text] [Related]
33. Using cholinergic M1 receptor positive allosteric modulators to improve memory via enhancement of brain cholinergic communication. Chambon C; Jatzke C; Wegener N; Gravius A; Danysz W Eur J Pharmacol; 2012 Dec; 697(1-3):73-80. PubMed ID: 23085025 [TBL] [Abstract][Full Text] [Related]
34. Novel Fused Arylpyrimidinone Based Allosteric Modulators of the M1 Muscarinic Acetylcholine Receptor. Mistry SN; Lim H; Jörg M; Capuano B; Christopoulos A; Lane JR; Scammells PJ ACS Chem Neurosci; 2016 May; 7(5):647-61. PubMed ID: 26891194 [TBL] [Abstract][Full Text] [Related]
36. Interaction studies of multiple binding sites on m4 muscarinic acetylcholine receptors. Lanzafame AA; Sexton PM; Christopoulos A Mol Pharmacol; 2006 Aug; 70(2):736-46. PubMed ID: 16709648 [TBL] [Abstract][Full Text] [Related]
37. Long-term activation upon brief exposure to xanomleline is unique to M1 and M4 subtypes of muscarinic acetylcholine receptors. Šantrůčková E; Doležal V; El-Fakahany EE; Jakubík J PLoS One; 2014; 9(2):e88910. PubMed ID: 24558448 [TBL] [Abstract][Full Text] [Related]
38. Synthesis and Pharmacological Evaluation of Heterocyclic Carboxamides: Positive Allosteric Modulators of the M Dallagnol JCC; Khajehali E; van der Westhuizen ET; Jörg M; Valant C; Gonçalves AG; Capuano B; Christopoulos A; Scammells PJ J Med Chem; 2018 Apr; 61(7):2875-2894. PubMed ID: 29544056 [TBL] [Abstract][Full Text] [Related]
39. Different interactions between MT7 toxin and the human muscarinic M1 receptor in its free and N-methylscopolamine-occupied states. Fruchart-Gaillard C; Mourier G; Marquer C; Stura E; Birdsall NJ; Servent D Mol Pharmacol; 2008 Dec; 74(6):1554-63. PubMed ID: 18784346 [TBL] [Abstract][Full Text] [Related]
40. Interpreting the structural mechanism of action for MT7 and human muscarinic acetylcholine receptor 1 complex by modeling protein-protein interaction. Xu J; Xu J; Chen H J Biomol Struct Dyn; 2012; 30(1):30-44. PubMed ID: 22571431 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]